The Why WAIT program: improving clinical outcomes through weight management in type 2 diabetes.
about
Anti-inflammatory nutrition as a pharmacological approach to treat obesityThe great debate: medicine or surgery: what is best for the patient with type 2 diabetes?Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.Lifestyle interventions for the treatment of class III obesity: a primary target for nutrition medicine in the obesity epidemic.Chronologically scheduled snacking with high-protein products within the habitual diet in type-2 diabetes patients leads to a fat mass loss: a longitudinal study.Diabetes Remission after Nonsurgical Intensive Lifestyle Intervention in Obese Patients with Type 2 Diabetes.Adjustable Gastric Band Surgery or Medical Management in Patients With Type 2 Diabetes: A Randomized Clinical Trial.Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Management of the metabolic syndrome and type 2 diabetes through lifestyle modification.Diabetes medications and body weight.Long-term effect of intensive lifestyle intervention on cardiovascular risk factors in patients with diabetes in real-world clinical practice: a 5-year longitudinal study.Effects of lifestyle changes to reduce risks of diabetes and associated cardiovascular risks: results from large scale efficacy trials.Protein content in diabetes nutrition plan.Nutrition therapy and the management of obesity and diabetes: an update.Diets for body weight control and health: the potential of changing the macronutrient composition.Dietary protein is important in the practical management of prediabetes and type 2 diabetes.Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.Physical Activity in Obese Type 2 Diabetes After Gastric Bypass or Medical Management.Partnering with patients to improve therapeutic outcomes: incretin-based therapy for type 2 diabetes.ASGE EndoVators Summit: Defining the Role and Value of Endoscopic Therapies in Obesity Management.Nonsurgical diabetes weight management: be prepared for sustainable and practical interventions.Anti-inflammatory Diets.Medications that cause weight gain and alternatives in Canada: a narrative review
P2860
Q34189477-292D6487-72BE-4C08-A4B6-B7EDB861081CQ34583457-F555CBBE-A57A-4A60-8298-38D9DF29427BQ34762353-F768E56C-03D6-461A-A2E9-B7BE3396E809Q35092502-6C6BAD87-85DE-4768-8457-9D391280D6BFQ35164048-AD2D1AC0-DE15-4F59-A33C-6618FC6C086BQ35737641-364364DF-B551-4B85-82E2-73F2BB703AA2Q35813224-051A0CB1-802F-4B2D-8D6A-DE640DF298D9Q37206402-1984A1BB-9172-47E5-BC8E-86B0617752A0Q37463193-7CF619D3-6B2D-4CE4-8EB1-FA78579D2A1BQ37524006-6F06C5A2-ABA3-4E48-8E07-ED5819DAEFFBQ37576698-41C12502-1A4C-4B97-8347-26DFB2F09129Q37635756-6B1A46FD-A454-40D3-B149-08CA4D37D6CFQ37826119-B94BD745-0D21-47BE-8B5B-AE0133D69DB8Q37829367-11A256B5-8228-4A36-81D6-17C329631B7EQ38063124-80D44AFE-4A48-485D-8CBC-EF7AE02BB0CEQ38295264-6FF02534-23C2-47E4-B0CC-4171A863CA08Q39452303-F3163E32-5870-4610-ADC2-2694A4683367Q39459884-F670825F-45E3-46B6-986E-537F8B17D0C6Q42171159-5F5DF3DD-2C99-4DFE-8F46-7B774143E969Q46084030-165DEC0C-2E6A-4EAA-9656-6CAF124120FCQ47396923-FF76BAE3-7C92-46A9-80CD-060B7B95D0D7Q53669034-A9956A48-1622-410F-B72C-BD0C94CBD561Q58729864-4176942F-84CD-43C8-8B58-B1F1630060DD
P2860
The Why WAIT program: improving clinical outcomes through weight management in type 2 diabetes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The Why WAIT program: improvin ...... management in type 2 diabetes.
@en
type
label
The Why WAIT program: improvin ...... management in type 2 diabetes.
@en
prefLabel
The Why WAIT program: improvin ...... management in type 2 diabetes.
@en
P1476
The Why WAIT program: improvin ...... management in type 2 diabetes.
@en
P2093
Catherine Carver
Osama Hamdy
P2888
P304
P356
10.1007/S11892-008-0071-5
P577
2008-10-01T00:00:00Z